comp_molregno,act_standard_units,act_standard_type,act_activity_comment,act_bao_endpoint,act_type,ass_assay_id,ass_description,ass_assay_type,ass_assay_category,ass_chembl_id,doc_doi,doc_pubmed_id,doc_chembl_id,doc_title,doc_doc_type,doc_abstract,doc_patent_id,coms_canonical_smiles,comp_full_molformula,mold_chembl_id,act_0
73518,%,Agonist activity,,BAO_0000179,Agonist activity,523676,Agonist activity at androgen receptor assessed as receptor transactivation by reporter gene assay at 500 nM,F,,CHEMBL997191,10.1021/jm900280m,19432422,CHEMBL1136927,Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit.,PUBLICATION,,,C[C@](O)(CBr)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,C11H10BrF3N2O4,CHEMBL296323,82.9
204763,%,Agonist activity,,BAO_0000179,Agonist activity,523675,Agonist activity at androgen receptor assessed as receptor transactivation by reporter gene assay at 100 nM,F,,CHEMBL997190,10.1021/jm900280m,19432422,CHEMBL1136927,Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit.,PUBLICATION,,,C[C@](O)(CSc1ccc(NC(=O)CCl)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,C20H17ClF3N3O3S,CHEMBL333745,97.5
